FR2987265B1 - PHARMACEUTICAL COMPOSITION IN THE FORM OF MODAFINIL-BASED SYRUP, METHOD FOR PRODUCING THE SAME AND APPLICATION THEREOF - Google Patents

PHARMACEUTICAL COMPOSITION IN THE FORM OF MODAFINIL-BASED SYRUP, METHOD FOR PRODUCING THE SAME AND APPLICATION THEREOF

Info

Publication number
FR2987265B1
FR2987265B1 FR1200579A FR1200579A FR2987265B1 FR 2987265 B1 FR2987265 B1 FR 2987265B1 FR 1200579 A FR1200579 A FR 1200579A FR 1200579 A FR1200579 A FR 1200579A FR 2987265 B1 FR2987265 B1 FR 2987265B1
Authority
FR
France
Prior art keywords
modafinil
producing
application
pharmaceutical composition
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1200579A
Other languages
French (fr)
Other versions
FR2987265A1 (en
Inventor
Christophe Lebon
Pascal Suplie
Julie Domergue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Debregeas Et Associes Pharma SAS
Original Assignee
Debregeas Et Associes Pharma SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debregeas Et Associes Pharma SAS filed Critical Debregeas Et Associes Pharma SAS
Priority to FR1200579A priority Critical patent/FR2987265B1/en
Priority to TW102106510A priority patent/TW201340994A/en
Priority to PCT/FR2013/000050 priority patent/WO2013128086A1/en
Priority to ARP130100594A priority patent/AR090167A1/en
Publication of FR2987265A1 publication Critical patent/FR2987265A1/en
Application granted granted Critical
Publication of FR2987265B1 publication Critical patent/FR2987265B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR1200579A 2012-02-28 2012-02-28 PHARMACEUTICAL COMPOSITION IN THE FORM OF MODAFINIL-BASED SYRUP, METHOD FOR PRODUCING THE SAME AND APPLICATION THEREOF Expired - Fee Related FR2987265B1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR1200579A FR2987265B1 (en) 2012-02-28 2012-02-28 PHARMACEUTICAL COMPOSITION IN THE FORM OF MODAFINIL-BASED SYRUP, METHOD FOR PRODUCING THE SAME AND APPLICATION THEREOF
TW102106510A TW201340994A (en) 2012-02-28 2013-02-25 A pharmaceutical composition appearing as a syrup of modafinil, its method for manufacturing and its application
PCT/FR2013/000050 WO2013128086A1 (en) 2012-02-28 2013-02-25 Modafinil-based pharmaceutical composition in syrup form, process for the production thereof and use thereof
ARP130100594A AR090167A1 (en) 2012-02-28 2013-02-27 PHARMACEUTICAL COMPOSITION WHOSE ACTIVE PRINCIPLE IS THE MODAFINILO IN ITS FORM OF A CHARMER PRESENTING HIMSELF AS A SYRUP

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1200579A FR2987265B1 (en) 2012-02-28 2012-02-28 PHARMACEUTICAL COMPOSITION IN THE FORM OF MODAFINIL-BASED SYRUP, METHOD FOR PRODUCING THE SAME AND APPLICATION THEREOF

Publications (2)

Publication Number Publication Date
FR2987265A1 FR2987265A1 (en) 2013-08-30
FR2987265B1 true FR2987265B1 (en) 2014-02-28

Family

ID=48083445

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1200579A Expired - Fee Related FR2987265B1 (en) 2012-02-28 2012-02-28 PHARMACEUTICAL COMPOSITION IN THE FORM OF MODAFINIL-BASED SYRUP, METHOD FOR PRODUCING THE SAME AND APPLICATION THEREOF

Country Status (4)

Country Link
AR (1) AR090167A1 (en)
FR (1) FR2987265B1 (en)
TW (1) TW201340994A (en)
WO (1) WO2013128086A1 (en)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5618845A (en) * 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
US6919378B2 (en) 2000-10-11 2005-07-19 Cephalon, Inc. Pharmaceutical solutions of modafinil compounds
EA005591B1 (en) * 2000-10-11 2005-04-28 Сефалон, Инк. Compositions comprising modafinil compounds
US6489363B2 (en) 2000-10-11 2002-12-03 Cephalon, Inc. Pharmaceutical solutions of modafinil compounds
US7576133B2 (en) 2002-03-11 2009-08-18 Carl Henry Lawyer Methods and compositions for nasal administration of modafinil
US20040116532A1 (en) * 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil
US20050008704A1 (en) 2003-07-11 2005-01-13 Ray Anup Kumar Pharmaceutical composition for solubility enhancement of hydrophobic drugs
US20060024370A1 (en) * 2004-07-29 2006-02-02 Cephalon France Modafinil oral lyophilizate
EP1891938A1 (en) * 2006-07-24 2008-02-27 Cephalon France High dose orally dissolvable/disintegrable lyophilized dosage form
US8173169B2 (en) * 2007-07-11 2012-05-08 Hikma Pharmaceuticals Formulation and process for the preparation of modafinil

Also Published As

Publication number Publication date
AR090167A1 (en) 2014-10-22
WO2013128086A1 (en) 2013-09-06
FR2987265A1 (en) 2013-08-30
TW201340994A (en) 2013-10-16

Similar Documents

Publication Publication Date Title
BR112013030472A2 (en) pharmaceutical formulation, article of manufacture and method
BR112013033811A2 (en) composition, method of preparing the composition, and
BR112013031916A2 (en) nucleic composition, use of a nutritional composition, process for making a nutritional composition, and product
BR112014010391A2 (en) compound, pharmaceutical composition, process of producing a pharmaceutical composition, method of treatment, kit and use of a pharmaceutical composition
BR112014010460A2 (en) compound, pharmaceutical composition, process for producing a pharmaceutical composition, method of treatment, kit and use of a pharmaceutical composition
BR112013007276A2 (en) pharmaceutical composition, process for preparing a pharmaceutical composition, use of pharmaceutical composition and method for treating chronic iron overload
BR112012026843A2 (en) composition, pharmaceutical composition, process for preparing a pharmaceutical composition, use of a composition and method for treating HIV
SG11201408156PA (en) Mold base material, production method for mold base material, mold production method, and mold
BR112014020603A2 (en) gel forming composition, glazing unit, process for forming a glazing unit, and method for making a gel forming composition
EP2851421A4 (en) Useful microorganism, and method for producing desired substance
CO6862129A2 (en) Apparatus and process for the production of an encapsulated cell product
BR112012021066A2 (en) process of preparing a composition, composition and applying the composition
PL2770827T3 (en) Composition, method for producing the composition, and phytosanitary formulation containing same
BR112014026565A2 (en) formulation, use of a formulation, and process for producing a formulation
BR112015026371A2 (en) composition for preparing probiotic bacteria, liquid food product, process for preparing probiotic bacteria, and process for preparing a liquid based food product
FR2985734B1 (en) BIOCOMUSABLE COMPOSITION AND METHOD FOR MANUFACTURING BIOCOMBUSTIBLE
BR112013022930A2 (en) pharmaceutical composition, use of a pharmaceutical composition, and process for producing a pharmaceutical composition
BR112014025972A2 (en) anamorelin monohydrochloride, composition, process for preparing anamorelin monohydrochloride, pharmaceutical composition and method for producing a pharmaceutical dosage form
BR112012025490A2 (en) '' method for the production of 1,5 oebtanodiamine ''
EP2742946A4 (en) Method for producing pyrostegia venusta derivatives, pyrostegia venusta derivatives, pharmaceutical compositions and uses thereof
BR112013015501A2 (en) compound, pharmaceutical composition, methods for treating viral infections and inflammatory disorders, and the process for producing a miasynthetic sangliferrin
BR112013013415A2 (en) pharmaceutical composition, and method for preparing a pharmaceutical composition
BR112014011745A2 (en) pharmaceutical composition and process for the manufacture of a hydrocortisone pharmaceutical composition
ZA201407558B (en) Itq-49 material, method for the production thereof and use of same
FI20116234A (en) The method of making the base material and the base material

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

ST Notification of lapse

Effective date: 20201005